For qRT-PCR, Western blot, and immunohistochemistry assays, clinical samples such as peripheral blood and CRC tissues were gathered to validate that lncRNA-NEAT1 can knock down proliferation and migration of CRC cells by mediating immune inflammatory responses (Chen et al. 2022). The gene discussed is NEAT1; the disease is colorectal carcinoma.